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EDITORIAL 
Monoclonal antibodies (mAbs) are broadly used in medical research, 
therapeutics and diagnostics (Jorgensen et al., 2007). mAbs are among the best-
selling class of biopharmaceutics (Ho et al., 2013). The in vitro hybridoma culture is 
an appropriate method for monoclonal antibody production using the culture 
supernatant (Falkenberg et al., 1995; Sen and Roychoudhury, 2013). The production 
of recombinant therapeutic biologics in cell culture is a rapidly growing industry, 
creating many opportunities for bioprocess engineering research and development. 
To meet this increasing demand for therapeutic biologics, the primary goal of 
increasing the yield of bioprocesses, either by increasing maximum cell densities of 
cultures, or improving hybridoma cell culture that requires optimizing the nutrient 
medium in order to support cell growth, reduce cell death, and enhance mAb 
production (Kelley, 2009). Supplemental feeding of amino acids has proven effective 
for improving cell viability (Duval et al., 1991) and protecting cells from apoptosis-
induced death and nutrient deprivation (Ducommun et al., 2001). 
The cell line and its recombinant DNA construct, culture media, and process 
conditions are known to have a significant effect on the expression and stability of 
therapeutic products. Perhaps, the most important and crucial step in cell culture, 
however, is the selection of appropriate growth medium for in vitro cultivation (Zarei 
et al., 2014). The cell culture medium provides an artificial environment conducive to 
survival and proliferation of cultured cells and maintains the desired pH and 
osmolality. The choice of cell culture media has been known to significantly affect the 
physiochemical characteristics of mAbs. The selection of the media depends on the 
type of cells to be cultured and also the purpose of the culture and resources. The 
complexity of composition of cell-culture media offers many challenges towards 
optimization of the individual media components. Synthetic or chemically defined 
media are prepared by adding defined concentration of nutrients (both organic and 
inorganic) such as vitamins, salts, traces elements, carbohydrates, and cofactors. 
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CHO are supplied largely in the form of glucose as a 
carbon source for the hybridoma cells. Besides glucose is 
the energy source and supplementation with glucose 
supports viable cells in extended stationary phase. In some 
cases, glucose is substituted with other sugars to improve 
cell growth, viability and protein production (Wilkens et al., 
2011). Many previous studies focused on glucose and 
glutamine feeding to progress a strategy for procuring 
improved cell performance (Glacken et al., 1986). In 
numerous researches, glutamine supplementation did not 
stimulate cell proliferation (Geaugey et al., 1989) or show a 
reasonable growth supportive effect (Franek, 1995).  
In our study, four test media containing RPMI-1640, 
10% FBS, and penicillin/streptomycin, supplemented with 
glucose (control), fructose, galactose and maltose at 
concentration of 15 mg/mL each as carbon sources were 
used for cell culture. Cells were cultured in a humidified 
atmosphere of 5% CO2 at 37°C to optimize media 
components. Spleen cells were isolated from the 
immunized mice and mixed with Sp2/0 murine myeloma 
cells at ratio of 1:10 in presence of 1mL 50% PEG. Cell 
fusion and hybridoma culture procedures were carried out 
essentially following previous reports by limiting dilution 
(Ling et al., 2014; Ling et al., 2018; Ling et al., 2015). The 
most effective culture medium for hybridoma clones was 
supplemented with maltose that achieved best titer as 
determined by icELISA. Viable hybridoma cell densities 
were increased when supplemented with maltose as 
compared to the control. The monoclonal antibody 
produced by using supplemented culture media was 
specific. Another study evaluated the use of maltose 
supplementation in the production of a recombinant 
monoclonal antibody, demonstrating improvements in 
recombinant monoclonal antibody titer (Leong et al., 2018). 
Therefore, the use of supplemented cell culture media is an 
effective approach for enhanced production of 
monospecific-antibody, better hybridoma growth and 
viability. 
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